These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19380207)

  • 1. Specific medical intervention for diabetic retinopathy.
    Ng JS
    Med Hypotheses; 2009 Aug; 73(2):158-60. PubMed ID: 19380207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C beta inhibitors: a new therapeutic target for diabetic nephropathy and vascular complications.
    Budhiraja S; Singh J
    Fundam Clin Pharmacol; 2008 Jun; 22(3):231-40. PubMed ID: 18485142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of protein kinase C might be harmful to diabetic retinopathy.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2004; 63(1):135-7. PubMed ID: 15193366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of diabetic retinopathy.
    Lang GE
    Ophthalmologica; 2007; 221(2):112-7. PubMed ID: 17380065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKC inhibition and diabetic microvascular complications.
    Clarke M; Dodson PM
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):573-86. PubMed ID: 18054736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease.
    Tuttle KR; McGill JB; Haney DJ; Lin TE; Anderson PW;
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):631-6. PubMed ID: 17699475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic retinopathy: current management and experimental therapeutic targets.
    Ali TK; El-Remessy AB
    Pharmacotherapy; 2009 Feb; 29(2):182-92. PubMed ID: 19170588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in biochemical mechanisms of diabetic retinopathy.
    Giusti C; Gargiulo P
    Eur Rev Med Pharmacol Sci; 2007; 11(3):155-63. PubMed ID: 17970231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factors and protein kinase C inhibitors as novel therapies for the medical management diabetic retinopathy.
    Aiello LP; Cahill MT; Cavallerano JD
    Eye (Lond); 2004 Feb; 18(2):117-25. PubMed ID: 14762400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approaches and perspectives in the medical treatment of diabetic retinopathy.
    Porta M; Allione A
    Pharmacol Ther; 2004 Aug; 103(2):167-77. PubMed ID: 15369682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy.
    Curtis TM; Scholfield CN
    Diabetes Metab Res Rev; 2004; 20(1):28-43. PubMed ID: 14737743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic retinopathyA clinical update.
    Porta M; Bandello F
    Diabetologia; 2002 Dec; 45(12):1617-34. PubMed ID: 12488951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications.
    Joy SV; Scates AC; Bearelly S; Dar M; Taulien CA; Goebel JA; Cooney MJ
    Ann Pharmacother; 2005 Oct; 39(10):1693-9. PubMed ID: 16160002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruboxistaurin: PKC-beta inhibition for complications of diabetes.
    Danis RP; Sheetz MJ
    Expert Opin Pharmacother; 2009 Dec; 10(17):2913-25. PubMed ID: 19929710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic retinopathy.
    Davidson JA; Wilkes SR
    J Med Assoc Ga; 1989 Nov; 78(11):763-4. PubMed ID: 2691604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C-beta inhibition for diabetic kidney disease.
    Tuttle KR
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S70-4. PubMed ID: 18977550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of 20 years of research on the treatment of diabetic retinopathy.
    Ferris FL
    Prev Med; 1994 Sep; 23(5):740-2. PubMed ID: 7845951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin in diabetic retinopathy.
    Croxen R; Baarsma GS; Kuijpers RW; van Hagen PM
    Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():518-24. PubMed ID: 16444186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eye care: diabetic retinopathy.
    Leff SR; Masciulli L; Yarian DL; Green SN; Kushner MS
    N J Med; 1994 Apr; 91(4):251-5. PubMed ID: 8202272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruboxistaurin (Eli Lilly).
    Wheeler GD
    IDrugs; 2003 Feb; 6(2):159-63. PubMed ID: 12789620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.